International Isotopes Inc. (INIS)
OTCMKTS: INIS · Delayed Price · USD
0.0395
-0.0040 (-9.20%)
Jul 3, 2024, 11:26 AM EDT - Market closed

International Isotopes Revenue

International Isotopes had revenue of $12.08M in the twelve months ending March 31, 2024, with 5.39% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $2.90M, a -5.99% decrease year-over-year. In the year 2023, International Isotopes had annual revenue of $12.27M with 9.71% growth.

Revenue (ttm)
$12.08M
Revenue Growth
+5.39%
P/S Ratio
1.71
Revenue / Employee
$309,803
Employees
39
Market Cap
20.66M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202312.27M1.09M9.71%
Dec 31, 202211.18M1.52M15.73%
Dec 31, 20219.66M297.05K3.17%
Dec 31, 20209.36M409.69K4.57%
Dec 31, 20198.96M-1.41M-13.63%
Dec 31, 201810.37M2.95M39.73%
Dec 31, 20177.42M868.24K13.25%
Dec 31, 20166.55M-510.05K-7.22%
Dec 31, 20157.06M-474.66K-6.30%
Dec 31, 20147.54M687.71K10.04%
Dec 31, 20136.85M-772.78K-10.14%
Dec 31, 20127.62M-1.84M-19.45%
Dec 31, 20119.46M3.35M54.93%
Dec 31, 20106.11M-15.56K-0.25%
Dec 31, 20096.12M520.40K9.29%
Dec 31, 20085.60M911.86K19.44%
Dec 31, 20074.69M221.05K4.95%
Dec 31, 20064.47M1.48M49.71%
Dec 31, 20052.99M136.59K4.79%
Dec 31, 20042.85M778.25K37.59%
Dec 31, 20032.07M-111.11K-5.09%
Dec 31, 20022.18M3.80K0.17%
Dec 31, 20012.18M-4.10M-65.30%
Dec 31, 20006.28M2.59M70.13%
Dec 31, 19993.69M1.68M83.63%
Dec 31, 19982.01M1.87M1,379.88%
Dec 31, 1997135.77K-664.24K-83.03%
Dec 31, 1996800.00K--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 379.49B
Johnson & Johnson 81.80B
Merck & Co. 61.40B
AbbVie 54.40B
Novartis AG 49.92B
AstraZeneca 47.61B
Thermo Fisher 42.49B
Abbott Laboratories 40.33B
Revenue Rankings